Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Survey, Economic News/Analysis

64% of Construction Lenders and Real Estate Developers Report Adopting Software to Stay Ahead in 2023


Rabbet, the leading provider of construction finance software, today released its highly anticipated 2023 State of Construction Finance Report, which provides invaluable insights into the current landscape of construction finance, the perceptions of construction finance processes, and the relationship between lender and borrower.

Key findings include:

Processes that have been relatively unchanged in decades - if ever - are finally being updated.

To compile the data, Rabbet distributes a survey each year to lenders and developers representing a diverse portfolio size. The survey questions addressed the impact to their construction finance process, data management and collaboration. The data from 2023 was then compared to data collected in prior years. This report dives into insights, data, and trends for commercial real estate lenders and developers in 2023.

This year's report revealed that lenders and developers understand that they must optimize operations to account for the uncertainty of the future. The complexity of the draw process still creates unnecessary delays for both lenders and developers; however, over half of the industry is claiming that software of some kind is helping their teams be more productive.

According to Rabbet's CEO and Co-Founder, Will Mitchell, "Our latest State of Construction Finance Report revealed how critical software adoption is for this industry. In a time when deal volume is down, industry leaders are investing their teams time in preparing for the future. Leveraging the power of software and artificial intelligence is one of the clearcut ways of gaining a competitive advantage right now. While so many factors like material costs and interest rates are out of our control, assessing your operations and implementing technology is the best way to maximize returns for 2023 and strengthen your organization for the years to come."

To view the complete 2023 State of Construction Finance Report, click here.

About Rabbet

Rabbet is transforming the construction finance industry with tailored solutions that provide a complete picture of construction and asset management portfolios. Designed for real-time workflows and comprehensive insights, Rabbet enables real estate developers, construction lenders, and related service providers to lower operational costs, make more informed decisions, and earn trust with other financial stakeholders. Founded in Austin, TX in 2017, Rabbet has improved visibility and efficiency for over $50B in construction and capital expenditure projects. For more information about Rabbet, visit rabbet.com.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: